Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 312.50
Bid: 312.00
Ask: 312.50
Change: -2.50 (-0.79%)
Spread: 0.50 (0.16%)
Open: 310.00
High: 314.50
Low: 310.00
Prev. Close: 315.00
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

21 Dec 2007 07:00

Morgan Crucible Co PLC21 December 2007 The Morgan Crucible Company plc ("Morgan Crucible") agrees to acquire the Technical Ceramics businesses of Carpenter Technology Corporation for US$147 million Morgan Crucible is pleased to announce that it has agreed to acquire twotechnical ceramics businesses, Certech and Carpenter Advanced Ceramics, fromCarpenter Technology Corporation of the US. The businesses will be acquired on acash and debt free basis for a cash consideration of US$147 million (c. £73million). Certech manufactures a broad range of complex injection moulded ceramiccomponents. Certech is the global number one independent manufacturer of theseconsumable parts, which are used during the investment casting of turbine bladesand vanes for aerospace engines and industrial gas turbines, and some high endindustrial castings. The business also manufactures a range of other porousceramics and various foundry supplies. Certech has seven plants in the US, UKand Mexico and has approximately 750 employees. Carpenter Advanced Ceramics is a manufacturer of engineered ceramics productsvery similar to those of our existing Technical Ceramics operations. It sellshigh purity alumina and zirconia structural ceramic components for a variety ofapplications and industries and is a world leader in zirconia ceramics. Itoperates two plants, one in the US and one in Australia, and has approximately150 employees. Both acquisitions are strongly aligned with the Group's existing core ceramictechnology and with its strategic priorities of focusing on higher growth,higher margin, less economically cyclical markets. Following completion, Certechand Carpenter Advanced Ceramics will become part of Morgan Crucible's TechnicalCeramics division. In the financial year ended 30th June 2007 Certech and Carpenter AdvancedCeramics in aggregate reported US$91 million (c. £45 million) of revenue, anunderlying operating profit margin of over 15% and profit before tax of US$14.3million (c. £7.1 million). The acquisition will be immediately accretive to theGroup's operating profit margin and to its earnings per share, adding c.0.5pence in 2008.* Mark Robertshaw, Chief Executive Officer of Morgan Crucible, said: "Today'sacquisitions are in-line with our strategic priority of focusing on highergrowth, higher margin, less economically-cyclical markets. They also enhance ourhigh value-added offering to customers and reinforce the standing of ourTechnical Ceramics division as a global market leader in its chosen fields. Thestrength of our balance sheet has afforded us the flexibility to seek such valueaccretive acquisitions. Our Group overall order book remains robust and theoutlook for top line and margin growth is positive." Andrew Hosty, Chief Executive Officer of the Technical Ceramics division said:"This is an exciting addition to our Technical Ceramics business. It supportsour goal of delivering mid-teen margins and increases our presence in thegrowing aerospace sector." Enquiries:Victoria Gould, The Morgan Crucible Company plc 01753 837306Robin Walker / Clare Strange, Finsbury 020 7251 3801 Note for Class 2 purposes: As at 30th June 2007, Certech and Carpenter Advanced Ceramics had combined grossassets of $58.2 million (c £28.9 million). The closing of the transaction is subject to obtaining certain regulatoryclearances which are expected to be completed in early 2008. * Nothing in this announcement constitutes a profit forecast, and the impact ofthese acquisitions on Morgan Crucible's earnings per share and operating profitmargin in 2008 is not the only factor likely to give rise to a change from thefigures reported in the previous financial period. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Jun 20249:32 amRNSDirector/PDMR Shareholding
12th Jun 202412:05 pmRNSDirector/PDMR Shareholding
3rd Jun 20243:52 pmRNSDirector/PDMR Shareholding
22nd May 20245:17 pmRNSDirector/PDMR Shareholding
10th May 20245:21 pmRNSDirector/PDMR Shareholding
9th May 20241:59 pmRNSResult of AGM
9th May 20247:00 amRNSQ1 Trading Update
1st May 20245:38 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSCapital Markets Update
5th Apr 202412:55 pmRNSAnnual Financial Report
4th Apr 20241:16 pmRNSDirector/PDMR Shareholding
27th Mar 20244:52 pmRNSDirector/PDMR Shareholding
27th Mar 20244:50 pmRNSDirector/PDMR Shareholding
27th Mar 20244:49 pmRNSDirector/PDMR Shareholding
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
14th Mar 20249:42 amRNSDirector/PDMR Shareholding
14th Mar 20249:41 amRNSDirector/PDMR Shareholding
13th Mar 202412:10 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSMorgan Advanced Materials Full Year 2023 Results
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20231:56 pmRNSDirector/PDMR Shareholding
18th Dec 20234:25 pmRNSBlock listing Interim Review
22nd Nov 202310:07 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSQ3 Trading Update
9th Oct 20234:43 pmRNSDirector/PDMR Shareholding
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.